Assignee
SHENZHEN CHIPSCREEN BIOSCIENCES CO LTD
CN·9 granted patents·15 pending applications·16 citations·filing 2017–2023
Top patents by PatentIndex Score
24 records- 0188US10654815B2Urea compound and preparation method and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Granted May 19, 2020·15 cites·25 claims
- 0273US10640465B2Method for preparing phenylalanine compoundSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Granted May 5, 2020·1 cites·10 claims
- 0367US12577260B2Biphenyl compound as immunomodulator, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2023·Granted Mar 17, 2026·0 cites·10 claims
- 0460US11866452B2Biphenyl compound as immunomodulator, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2021·Granted Jan 9, 2024·0 cites·2 claims
- 0559US2026070885A1Trka (g667c) and flt3 target inhibitor and combination of same with chidamideSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 0657US12551478B2Quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activitySHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Granted Feb 17, 2026·0 cites·5 claims
- 0754US11981638B2Phenyl amino sodium propionate derivative, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Granted May 14, 2024·0 cites·9 claims
- 0853US2024101548A1Hydroxamate compound, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 0952US2022000848A1Application of chidamideSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 1051US2023117545A1Pharmaceutical composition comprising protein kinase inhibitor and chemotherapeutic drug and use thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 1151US2023321074A1Use of chiauranib in combination with immune checkpoint inhibitor in antitumor therapySHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 1250US2024382480A1Pharmaceutical composition containing jak3/jak1/tbk1 selective inhibitor and medical use thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 1348US10882825B2Non-solvated crystal, preparation method and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Granted Jan 5, 2021·0 cites·16 claims
- 1448US2021315881A1Combination of histone deacetylase inhibitor and protein kinase inhibitor and pharmaceutical use thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 1547US2021386705A1Application of chiglitazar and related compounds thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 1647US2022387430A1Use of compound in preventing or treating graft versus host diseaseSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 1746US2023000863A1Composition containing aromatic heterocyclic compound in amorphous form, and preparation method therefor and use thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 1845US12194054B2Application of Chidamide in combination with R-CHOP, and drug combinationSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Granted Jan 14, 2025·0 cites·4 claims
- 1945US2022401425A1Chidamide pharmaceutical composition, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 2044US2022184056A1Use of kdm5a gene and atrx geneSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 2142US2022184055A1Chiauranib for treatment of small cell lung cancerSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 2240US2021139454A1Formamide compound, preparation method therefor and application thereofSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2019·Application pending·0 cites
- 2339US10604529B2Fused imidazole compound having indoleamine 2,3-dioxygenase inhibitory activitySHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Granted Mar 31, 2020·0 cites·19 claims
- 2432US2020031771A1Substituted phenylpropionic acid enantiomer and manufacturing method, composition, and application of sameSHENZHEN CHIPSCREEN BIOSCIENCES CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHENZHEN CHIPSCREEN BIOSCIENCES CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →